Point 9 Labs will be presented at the AGP Spring Consumer Cannabis Conference and the Benzinga Small Cap Conference in May


PHOENIX, April 28, 2021 / PRNewswire / – Item 9 Labs Corp. (OTCQX: FADN) (“Item 9 Labs” or the “Company”), a vertically integrated franchisor and cannabis dispensary operator that makes award-winning premium products, announced today that it will participate in the AGP Spring Consumer Cannabis Conference and the Benzinga Global Small Cap Conference in May 2021.

“The US cannabis market is facing significant growth,” said Item 9 Labs CEO Andrew Bowden. “Our franchise model for the pharmacy Unity Rd. Combined with our premium products from Item 9 Labs puts us in a position to benefit financially as well as geographically. At these conferences we will discuss how franchising is the most viable national expansion strategy for our pharmacy brand Unity Rd. Comes with heavily reduced investments, resulting in accelerated scaling. “

Virtual one-on-one meetings at the AGP Spring Consumer Cannabis Conference

– Date: Tuesday May 4th 2021
– Interested investors: Please contact your AGP registered agent

Bowden, chief strategy officer Jeffrey Rassás and Chief Franchise Officer Mike Weinberger will Meet with investors in one-on-one meetings. The conference includes up to 30 selected companies in the cannabis industry and is attended by around 200 qualified institutional investment funds from around the world.

Presentation at the Benzinga Global Small Cap Conference

– Date: Thursday May 13th 2021
– Time: 10:10 a.m. EDT
– Registration link: https://www.benzinga.com/events/small-cap/global/

Bowden and Weinberger provide an overview of the company, including award-winning Item 9 Labs products, growing area expansion, and other key initiatives. They will also discuss in depth the value of the recently completed acquisition of ONE Cannabis Group (OCG Inc.) and its Unity Rd franchise brand, including how the combined offerings can accelerate the company’s growth in the current favorable regulatory climate .

The Benzinga Global Small Cap Conference is designed to bridge the gap between listed small cap companies, investors and traders. It enables the management of small-cap companies to network and communicate with a broad and diverse global investor base in a virtual environment.

Information on Article 9 Labs Corp.
Item 9 Labs Corp. (OTCQX: FADN) is a vertically integrated cannabis operator and franchisor that supplies premium products from its large cultivation and manufacturing facilities in Canada The United States. The award-winning Item 9 Labs brand specializes in providing world-class products and user experiences across a range of cannabis categories. The company also offers a unique franchise model for pharmacies via the national Unity Road. Retail brand. The franchise eases the barriers to entry and provides both new and existing pharmacy owners with the opportunity to leverage the knowledge, resources, and ongoing support needed to conformally and successfully thrive in their state. Item 9 Labs brings the best industry practices to market nationwide through distinctive retail experience, grow capabilities, and product innovation. The seasoned management team combines diverse skills with years of experience in the cannabis sector, franchising and capital markets to lead a new generation of public cannabis companies that deliver transparency, consistency and wellbeing. Headquarters in ArizonaThe company is currently expanding its operating space on its 50 acre site, one of the largest properties in, by more than 650,000 square feet Arizona Zones for growing and cultivating flowers. Please visit item9labscorp.com for more information.

Media contact:
Item 9 laboratories
Jayne Levy, Communications director
Phone: 480-542-9421
E-mail: [email protected]

Investor contact:
Item 9 laboratories
Phone: 800-403-1140
E-mail: [email protected]

SOURCE Item 9 Labs Corp.

similar links